National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

bismuth subsalicylate
A bismuth salt of salicylic acid. Little absorbed from the gastrointestinal tract, bismuth subsalicylate exerts a local effect on the gastric mucosa, coating it and protecting it from the corrosive effects of acid and pepsin. This agent also has local antimicrobial properties. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Pepto-Bismol



Previous:Bioperine, BioResponse DIM, biricodar dicitrate, bisantrene hydrochloride, bismuth Bi213 monoclonal antibody M195
Next:bispecific antibody 2B1, bispecific antibody 4G7xH22, bispecific antibody MDX-H210, bispecific antibody MDX447, bizelesin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov